Total number of publications: 44
Articles
-
A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study
British journal of haematology, year: 2024, DOI
-
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
New England Journal of Medicine, year: 2024, DOI
-
Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data
Cancer Medicine, year: 2024, volume: 13, edition: 17, DOI
-
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI
-
Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease
Blood Cancer Journal, year: 2024, volume: 14, edition: 1, DOI
-
Dual Nature of MoO3 Particles in Human-Derived Macrophage Milieu
ACS Applied Nano Materials, year: 2024, DOI
-
Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab-exposed relapsed/refractory multiple myeloma patients: A retrospective analysis
European Journal of Haematology, year: 2024, DOI
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
Leukemia, year: 2024, DOI
-
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
Journal of clinical oncology, year: 2024, volume: 42, edition: 16, DOI
-
FoxO1/Rictor axis induces a non-genetic adaptation to Ibrutinib via Akt activation in chronic lymphocytic leukemia
The Journal of Clinical Investigation, year: 2024, DOI